Campbell Neurosciences, inc.

Thomas E. Ichim, Ph.D. – Chief Executive Officer and Director

Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date, he has published 121 peer-reviewed articles and is co-editor of the textbooks “RNA Interference: From Bench to Clinical Translation” and “Immuno-Oncology Text Book.”

Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr. Ichim is an inventor on 135 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.

Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, an MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D. in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.

Jona Barnes, Chief Financial Officer

Jona Barnes is an accomplished financial executive with over 33 years of experience in private and public companies with exceptionally strong analytical skills.   She is a result driven business partner able to establish vision and drive strategies to strengthen top and bottom-line performance through “roll up the sleeves” hard work.

Jona holds a bachelor’s degree in Accounting from San Diego State University.  She has worked for several public accounting firms. She is a partner for 25 years at Mallett & Barnes Tax Services representing corporate and individual clients with financial management, tax and complex audit issues.

Raymond Oliver – Chairman

Raymond Oliver is CEO of Bear Creek Capital, Investor and entrepreneur. Mr. Oliver has assisted companies to get in position for financing and acceleration. Mr. Oliver been instrumental in sourcing capital for both private and public companies. Mr. Oliver have spent 35 years in the financial markets and has been on many sides. Mr. Oliver spent his first 10 years as a Series 7 and 63 licensed retail stockbroker managing all levels of equities markets. Mr. Oliver has spent many years working internally as an executive of multiple public companies. Mr. Oliver’s Introductions resulted in millions of dollars in equity financing in both public and private
companies. Capital market specialties include introductions to retail brokers, institutions, money managers, small cap funds, analyst and others. Many have been in his network for over 30 years. Mr. Oliver’s experience includes roles within several public and private companies whereas a value add he invested his own capital, secured top management and raised several millions of investment capital from the street. Mr. Oliver enjoys working with profitable companies that have strong management and are executing on their plan. Mr Oliver resides in Orlando with his wife and children for the past 30 years 

James Veltmeyer, MD – Chief Medical Officer

Dr. Veltmeyer is a board-certified family physician in La Mesa, California. A graduate of UC San Diego and the Ross University School of Medicine, he completed his residency through the UC San Francisco system where he became Chief of Family Medicine Residency, overseeing 36 doctors.

Dr. Veltmeyer, a member of the San Diego Critical Care Medical Group, has been elected for four years (2012, 2014, 2016, and 2017) by his colleagues in the San Diego County Medical Society as a “Physician of Exceptional Excellence,” the most prestigious honor awarded to a “Top Doctor” in San Diego County. He is among a select group of San Diego physicians who was chosen four of the last fifteen years and he consistently ranks in the top 1% to 2% for patient satisfaction. He is currently the Chief of the Department of Family Medicine at Sharp Grossmont Hospital where he provides senior leadership to over 200 doctors.

Ms. Kalina O’Connor – Founder and Chief Visionary Officer

Kalina O’Connor is the daughter of Kathleen Campbell, a victim of suicide who the Division Campbell Neurosciences is named after.  Kalina is a serial entrepreneur having experience in the area of counselling and biotechnology business development.  Kalina worked in various high-end suicide prevention/rehabilitation organizations for a decade, which provided her an intimate understanding of the shortcomings that exist in current approach to brain understanding and reprogramming.  Subsequently, Kalina was engaged with biotechnology organizations such as Therapsol and Bioscientific Holdings, providing introductions to licensing opportunities from academia.